Clinical Trials Logo

Ewing's Sarcoma Metastatic clinical trials

View clinical trials related to Ewing's Sarcoma Metastatic.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04183062 Active, not recruiting - Clinical trials for Osteosarcoma Metastatic

BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases

Start date: October 4, 2019
Phase: Phase 2
Study type: Interventional

This is a Phase 2 study of an investigational drug, BIO-11006, for the treatment of lung metastases in pediatric patients with advanced osteosarcoma or Ewing's sarcoma. This study will enroll up to 10 patients aged between 5 and 21 at Nicklaus Children's Hospital in Miami, FL. Patients will receive BIO-11006 in addition to chemotherapy consisting of gemcitabine and docetaxel. This study will test the hypothesis that BIO-11006 will enhance the effect of the gemcitabine and docetaxel chemotherapy to treat lung metastases in osteosarcoma and Ewing's sarcoma.